Abstract: Disclosed are a logistics management system and a logistics management method. The logistics management system includes: an order processing system receiving an order request for each order; a box making system capable of making order boxes for a plurality of reference standards, wherein one reference standard is different from another reference standard in at least one among size and intensity; and a central control device capable of selecting any one among the plurality of reference standards based on the order request, and transmitting a box making command indicating the selected reference standard to the box making system, wherein the box making system makes an order box with the selected reference standard in response to the box making command and supplies the order box to a box supply zone.

Abstract: A display device includes a display panel including a circuit element layer and a light emitting element layer on the circuit element layer, and a first light conversion layer, a second light conversion layer, and a light transmitting layer on the display panel and spaced apart from one another. The light emitting element layer includes a pixel defining layer that defines light emitting openings that overlap the first light conversion layer, the second light conversion layer, and the light transmitting layer, a plurality of light emitting elements arranged in the light emitting openings, respectively, and a barrier wall on the pixel defining layer, the barrier wall being black in color. When viewed from above, the barrier wall is located between light emitting elements adjacent to each other among the plurality of light emitting elements and extends parallel to sides of the adjacent light emitting elements that face each other.

Abstract: The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or inhibiting a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the serum uric acid concentration in a patient with a hyperuricemia-related disease.

Abstract: The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or inhibiting a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the blood uric acid concentration in a patient with a hyperuricemia-related disease.

Abstract: The present invention relates to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and a method of treating or inhibiting a hyperuricemia-related disease using the same, and the pharmaceutical composition of the present invention may effectively reduce the blood uric acid concentration in a patient with a hyperuricemia-related disease.

Abstract: A display device and method of manufacturing same includes: a display panel having a pixel area and a peripheral area adjacent to the pixel area, a light control layer disposed on the display panel and at least partially overlapping the pixel area, a light blocking portion at least partially overlapping the peripheral area, and a protective layer disposed between the light control layer and the light blocking portion.

Abstract: The present invention relates to a method for forming a charge transport layer on a substrate. Specifically, the present invention provides a method for manufacturing a device comprising a charge transport layer, which enables a uniform charge transport layer to be formed by a solution process even on a large area substrate. The method for manufacturing a device comprising a charge transport layer, of the present invention, may comprise: a charge forming step of forming first polarity charges on a transparent conductive substrate; a polymer electrolyte coating forming step of forming, on the transparent conductive substrate on which the first polarity charges are formed, a polymer electrolyte coating layer of second polarity charges which have the opposite polarity to that of the first polarity charges; and a first charge transport layer forming step of coating the polymer electrolyte coating layer with nanoparticles having the first polarity charges so as to form a first charge transport layer.

Abstract: Example of a garment, such as a jacket, pullover, hoodie, hat, or the like, having a cinchable or adjustable opening between panels is provided. When cinched, the inner panel's functionality is reduced or concealed. When uncinched, the inner panel's functionality is increased or exposed.

Abstract: A color conversion substrate and a display device including the same are provided, the color conversion substrate including a substrate, color filter layers on the substrate, and arranged in a first direction, and in a second direction intersecting the first direction, a bank layer defining openings overlapping the color filter layers, and including a first bank part extending in the second direction, and second bank parts extending in the first direction from a side of the first bank part, and wavelength conversion layers in the openings of the bank layer, wherein the first bank part includes a recess recessed inwardly from a part of a second side opposite a first side on which the second bank parts are located.

Abstract: The display panel includes an upper display substrate including a plurality of pixel areas and a light blocking area, a lower display substrate. The upper display substrate includes a base substrate, a barrier part overlapping the light blocking area and disposed on the base substrate, a light blocking layer including a first light blocking portion disposed on the barrier part and a second light blocking portion disposed on the same layer as the barrier part to respectively overlap the pixel areas, a reflection layer including a first reflection portion disposed on the first light blocking portion and a second reflection portion disposed on the second light blocking portion, and a light control layer overlapping the pixel areas and disposed on the reflection layer. A plurality of openings passing through the second light blocking portion and the second reflection portion are defined in each of the pixel areas.

Abstract: A compound of the present invention, which is a tricyclic derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof, has an excellent inhibitory effect on serotonin activity and a pharmaceutical composition comprising same can be thus advantageously used for preventing or treating a metabolic disease associated with serotonin activation, etc.

Abstract: A color conversion member includes: a first sub-partition part having a width which decreases from a first surface toward a second surface; a second sub-partition part disposed on the first sub-partition part and having a width which increases from the first sub-partition part toward the second surface; and a partition part which is disposed on the second sub-partition part and includes a liquid-repellent part including a liquid-repellent additive.

Abstract: Provided are a cosmetic composition for inhibiting sebum hypersecretion and a method of inhibiting sebum hypersecretion using the same. According to the present invention, there may be provided the cosmetic composition of inhibiting and adjusting sebum secretion which is harmless to the human body with excellent skin safety and decreases activity of peroxisome proliferator activated receptor gamma (PPAR-?) to fundamentally decrease sebum overproduction, thereby providing the skin with an effective effect, and a method of using the same.

Abstract: The display panel includes an upper display substrate including a plurality of pixel areas and a light blocking area, a lower display substrate. The upper display substrate includes a base substrate, a barrier part overlapping the light blocking area and disposed on the base substrate, a light blocking layer including a first light blocking portion disposed on the barrier part and a second light blocking portion disposed on the same layer as the barrier part to respectively overlap the pixel areas, a reflection layer including a first reflection portion disposed on the first light blocking portion and a second reflection portion disposed on the second light blocking portion, and a light control layer overlapping the pixel areas and disposed on the reflection layer. A plurality of openings passing through the second light blocking portion and the second reflection portion are defined in each of the pixel areas.

Abstract: A display device and method of manufacturing same includes: a display panel having a pixel area and a peripheral area adjacent to the pixel area, a light control layer disposed on the display panel and at least partially overlapping the pixel area, a light blocking portion at least partially overlapping the peripheral area, and a protective layer disposed between the light control layer and the light blocking portion.

Abstract: A display device and method of manufacturing same includes: a display panel having a pixel area and a peripheral area adjacent to the pixel area, a light control layer disposed on the display panel and at least partially overlapping the pixel area, a light blocking portion at least partially overlapping the peripheral area, and a protective layer disposed between the light control layer and the light blocking portion.